RE: A Few Thoughts Schiff,
Good to see you posting again: although I disagree with your belief that you "have been wrong on this all the way down". Your posts have always been honest and fair, and were certainly well-respected by me.
Over the past several months, the sp has been driven down on small volumes. Over 99% of shares remained in strong hands. As I understand it, the last tests were statistically insignificant because of procedural errors in testing the UNTREATED mice. Therefore, there was no baseline available with which to compare the treated mice results. The results do not reflect poorly on the product: only on the testing process itself. Hopefully, we can get it right next time, and now we know that there will be a next time. I remain confident in the product (strong scientific team, NRC foundation, overall good results, long-term commitment from management). And now we have the financial commitment to see it through.
I remain patient and as confident as one can been with any new product development.